RxDoctor Payments Data

Eric Wright, MD

Plastic and Reconstructive Surgery · Little Rock, ARNPI 1588899645

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by AbbVie at 44.8% of the total.

$8,628in general payments, 2019–2025

Across 167 payments — averaging $51.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • KCI USA, Inc.$2K
  • Axogen$1K
  • Mentor Worldwide LLC$729
  • Galderma Laboratories, L.p.$198
  • Merz North America, Inc.$161
  • plus $455 from 11 others

What the payments were for

  • Consulting fees$2,00023%
  • Travel & lodging$2,12225%
  • Food & beverage$4,50652%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic and reconstructive surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$8,522
Medicare patients
16
Services billed
40

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib17$58
Ondansetron Hcl25$58
Gabapentin22$47
Oxycodone Hcl21$37

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →